Non Invasive Neurostimulation Devices Market Analysis: Emerging Growth Drivers, Strategic Trends & Key Segments Forecast to 2035

Neurostimulation technologies are being investigated and used across a growing range of neurological and neuropsychiatric applications. Unlike implanted stimulation systems, non-invasive devices deliver electrical or magnetic stimulation without requiring a surgical procedure.

Technologies such as transcranial magnetic stimulation (TMS) and transcranial electrical stimulation are contributing to the development of the non-invasive neurostimulation devices market.

For more details on the non-invasive neurostimulation devices market, please visit the following URL:

https://www.rootsanalysis.com/....reports/non-invasive

Antibody Drug Conjugate (ADC) Market Key Highlights and Future Opportunities Till 2035


The antibody drug conjugates market, valued at USD 15.47 billion in 2025, is projected to reach USD 18.57 billion in 2026 and USD 43.56 billion by 2035, representing a CAGR of 9.9% during the forecast period 2026 to 2035. Market growth is expected to be supported by the expanding global oncology therapeutics landscape, increasing commercialization of targeted cancer therapies, sustained industry investment, and the rising adoption of advanced treatment modalities across healthcare systems.

For more details on the market, please visit the following URL: https://www.rootsanalysis.com/....reports/antibody-dru

Anti-Aging Drugs Market Trends, Opportunities, Key Players, Growth Factors, Revenue Analysis, 2024-2035

I recently came across a report by Roots Analysis that really put things into perspective. According to them, the global anti-aging drugs market, valued at USD 79 million in 2025, is projected to reach USD 150 million in 2026 and USD 2,807 million by 2040, with a 23.3% CAGR during the forecast period 2026 to 2040.

Read More :- https://www.rootsanalysis.com/....reports/anti-aging-t